Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Helping Ovarian Cancer Patients Cope With Their Disease (HOPE) - Phase 2

NCT06666218 is registered in ClinicalTrials.gov with Fred Hutchinson Cancer Center as lead sponsor.

NCT NCT06666218
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06666218 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Helping Ovarian Cancer Patients Cope With Their Disease (HOPE) - Phase 2
Lead sponsor
Fred Hutchinson Cancer Center
Phase
Not applicable
Overall status
Suspended
Start date
February 24, 2025
Completion date
December 31, 2029
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent ovarian carcinoma